findmyKOL

Melissa Levoska, MD

Basic profile

Brigham and Women's Hospital

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyDermatologyFocusDermatology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Melissa Levoska is a Dermatology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 53 publications with 559 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
53publications

Distinct works indexed by OpenAlex, matched via ORCID.

559citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    32.8%
    Azole Antifungal22.2%
    Ketoconazole100%
    Part D48 patients
    Lincosamide Antibacterial5.6%
    Clindamycin Phosphate100%
    Part D12 patients

    + 2 more classes in this area

  • Dermatology

    25.4%
    Corticosteroid15.6%
    Triamcinolone Acetonide84%Halobetasol Propionate16%
    Part D<11 patients
    alpha-Hydroxy Acid4.6%
    Ammonium Lactate100%
    Part D<11 patients

    + 2 more classes in this area

  • Sensory organs

    18.3%
    Corticosteroid18.3%
    Clobetasol Propionate60%Hydrocortisone27%Betamethasone Diprop Augmented13%
    Part D<11 patients
Where care is delivered (Part B)11.2% facility · 88.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”